Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya

This image opens in the lightbox

News provided by

Glenmark Pharmaceuticals Ltd.

26 Jun, 2025, 12:17 GMT

Share this article

Share toX

Share this article

Share toX

EMALI, Kenya, June 26, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Kenya Limited, a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, a research-led global pharmaceuticals company, has launched a project on maternal, child health and sustainable livelihoods in partnership with Emali Dedicated Children's Agency (EDCA). The project titled Enhancing Maternal, Infant, and Young Child Nutrition (MIYCN) (0-5 yrs) and Sustainable livelihood focuses on improving nutrition outcomes and food security across Emali Mulala (Kibwezi West Sub County) and Poka Kenyewa ward (Kajiado East Sub County) in Makueni and Kajiado counties. This marks Glenmark's continued commitment to creating inclusive health and building on earlier interventions in the Kibera slums of Nairobi.

Continue Reading
This image opens in the lightbox
The event was attended by community members, the county government representatives, EDCA and Glenmark Teams

The program will provide nutritional and economic support to over 500 children from the Early Childhood Development (ECD) centres, more than 300 pregnant and lactating women, and over 240 vulnerable households. Additionally, 2,000 children under five will receive Vitamin A supplementation and deworming through community health outreach programs.

Structured around three core pillars, the program will:

  1. Provide nutritious meals through school-based feeding program
  2. Improve maternal-child health through focused nutritional support and health interventions
  3. Empower families economically by introducing poultry-based livelihoods that promote long-term food and income security

"We believe that health and wellbeing of children and mothers is one of the most powerful ways to build a healthier world. Glenmark's newly launched initiative in Emali, Kenya, along with our partners, is addressing child nutrition and maternal care that will further empower families and enrich lives in a sustainable way," said Cheryl Pinto, Executive Director – Corporate Services, Glenmark Pharmaceuticals Ltd.

"This initiative is a step forward in our commitment to advancing community health in Kenya," said Manish Bajaj, Country Manager, Glenmark Pharmaceuticals Kenya Ltd. "Through our partnership with EDCA and the county governments, we are working towards sustainable impact that supports the goals of the Kenya Vision 2030, particularly in the areas of health, nutrition, and livelihoods. We believe this effort will bring real change to the lives of children and mothers in these counties."

Hon. Benard Moloma, Member of County Assembly for Kenyewa Poka Ward, praised the project, stating, "This initiative is timely and offers a practical solution for our communities, where mothers and children continue to face nutritional challenges due to recurring droughts and limited healthcare access. By integrating nutrition, health, and sustainable livelihoods, we are tackling both immediate hunger and long-term resilience. We proudly support Glenmark and EDCA in making this change a reality."

Speaking on the initiative, Mr. Alex Kilowua, County Executive Committee Member (CECM) for Medical Services and Public Health in Kajiado County, said, "With stunting affecting nearly one in four children under five and many mothers struggling to access quality nutrition services, this initiative fills urgent gaps and complements our ongoing efforts to reduce maternal and child malnutrition. The collaboration between EDCA and Glenmark strengthens our county's health and nutrition strategy and showcases the power of multi-sector partnerships," he said.

Speaking on this partnership, EDCA CEO, Victor Aduda, stated, "The well-being of mothers and children is the foundation of a thriving society. This partnership with Glenmark allows us to provide not just immediate nutrition aid but also equip families with lasting tools for resilience through poultry farming, health, education, and locally driven solutions. Together, we are building a healthier, more self-reliant future for children and households in Makueni and Kajiado."

County governments and community leaders at the launch emphasized the vital role of multi-sectoral collaboration in tackling malnutrition. The project supports Kenya's Vision 2030 and national efforts to achieve Universal Health Coverage (UHC) and Sustainable Development Goal 2: Zero Hunger.

Through these initiatives, Glenmark and EDCA remain dedicated to community ownership and policy integration to bring about a positive change in the lives of the people of these counties.

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. Scrip 100 positions Glenmark amongst the Top 100 biopharmaceutical companies ranked by Pharmaceutical sales in 2023; while Generics Bulletin places it in the Top 50 Generics and biosimilar companies ranked by sales in 2024. Glenmark's Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), making it only the second pharmaceutical company in India to achieve this. The organization has impacted over 3.3 million lives over the last decade through its CSR interventions. For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).

About EDCA

Emali Dedicated Children's Agency (EDCA) is a registered Non-Governmental Organization working to create opportunities for Deprived, Excluded, and Vulnerable (DEV) children, with a focus on child survival, growth, and development. The organization empowers families and caregivers to meet their own needs, recognizing that sustainable family support is key to improving the lives of children. EDCA's core mission is to initiate, support, and scale up community-driven development projects that protect and empower children, while also enhancing climate-resilient livelihoods. The organization works in collaboration with like-minded partners to implement practical and sustainable interventions. EDCA operates across six key thematic areas: Child Protection, Education, Food Security and Livelihoods, Water, Sanitation and Hygiene (WASH), Health and Nutrition, and Climate Action. Through these integrated programs, EDCA is helping to build communities where children are safe, healthy, empowered, and able to thrive in environments supported by sustainable livelihoods. For more information, visit www.emalidca.org.

Photo: https://mma.prnewswire.com/media/2719779/Glenmark_EDCA_Kenya_Project.jpg
Logo: https://mma.prnewswire.com/media/451507/5389746/PRNE_Glenmark_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.